Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors

GAITHERSBURG, Md., Nov. 3 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Gregg Alton, J.D. to its Board as an independent Director. Mr. Alton brings extensive industry experience to his role on the Novavax Board of Directors, including more than 20 years at [...]